Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Apr 10;11:669–681. doi: 10.2147/OPTH.S126690

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Meier et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Mean olopatadine 0.77% plasma concentration over time (A) and AUC_0–12 (B) following single-dose (Day 1) and multiple-dose (Day 7) exposure.

Notes: ^#n=9 at 8- and 12-hour time points due to study consent withdrawal. Data for Day 7 AUC_0–12 are from 19 subjects. AUC_0–12, area under the plasma concentration–time curve from 0 to 12 hours.